SL
GH icon

Summitry LLC’s Guardant Health GH Stock Holding History

Summitry LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
+8,863
New +$964K 0.04% 83

Other funds holding GH

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $276M AUM 31.26% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
ITFISA
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Warsaw $300M AUM 61.93% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
FA
Fiduciary Alliance Greenville, South Carolina $1.48B AUM 24.99% 1-Year Est. Return

Summitry LLC's GH Position: Q2 2026 in Review

Summitry LLC opened a new position in Guardant Health (GH) in Q2 2026: 8,863 shares worth $1.33M. The stake represents 0.04% of the portfolio and ranks #83 among its holdings.

69 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Summitry LLC held 8,863 shares of Guardant Health worth $1.33M as of Q2 2026.
  • Guardant Health was a new Summitry LLC position in Q2 2026.
  • Guardant Health made up 0.04% of Summitry LLC's portfolio in Q2 2026, its #83 holding.
  • 69 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.